legal-news

AMERICAN REGENT, INC. v. MSN LABORATORIES PRIVATE LIMITED et al

24-cv-10674
Active Active litigation Sign in to follow this case
Share mail
Advertisement
description

Case Summary

American Regent, Inc. sued MSN Laboratories Private Limited and related defendants in a case docketed 24-cv-10674. American Regent is a pharmaceutical company; MSN Laboratories is an Indian generic drug manufacturer. The dispute almost certainly involves patent infringement under the Hatch-Waxman Act, the standard framework when a brand-name drug maker challenges a generic competitor's abbreviated new drug application. Filed in 2024, the case is in early stages. Hatch-Waxman litigation typically triggers a 30-month stay on Food and Drug Administration approval of the generic, giving the brand-name plaintiff time to litigate before market entry occurs.

No timeline activity recorded yet. This page will grow as rulings and filings land.

Key Issues

  • • Pharmaceutical patent infringement under Hatch-Waxman
  • • Generic drug market entry and 30-month stay
  • • Validity and enforceability of American Regent's patents
  • • MSN Laboratories' ANDA filing and patent certification
smart_toy Juryvine case summary generated from primary court records. How we verify our work.
Advertisement

Case Timeline

1 event
info
Other April 19, 2026

3:24-cv-10674 AMERICAN REGENT, INC. v. MSN LABORATORIES PRIVATE LIMITED et al

A case was filed in federal court captioned American Regent, Inc. v. MSN Laboratories Private Limited, docket 3:24-cv-10674. The event type is unspecified and no description was provided, leaving the nature of the dispute — likely a pharmaceutical patent challenge given the parties — unclear from the filing alone.

description View filing open_in_new
Advertisement
newspaper

Press Coverage

1 article
settings_backup_restore Data provenance expand_more

Sources tracked

1 outlet · 1 article

Timeline events

1 record on file

Last updated

1 hour, 57 minutes ago

Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.